REGISTER: thelimbic.com/nephrology/car… A MDT panel presents the latest updates on the use of disease-modifying treatments in cardio-renal metabolic disease and discusses models of care for improved patient outcomes. Brendon Neuen RathikaKrish Adam Nelson A/Prof Sarah Glastras ANZSN

Yet another indictment of aged care... about a third of elderly people with #diabetes in residential aged care facilities are not receiving guideline-directed medical therapy, an Australian study shows. ☹️ thelimbic.com/endocrinology/…

Endocrinologists have told a Senate Inquiry into #menopause about the need to balance the risks of pathologising a normal stage of life for most women v failure to recognise the impact of early menopause & premature ovarian insufficiency @HelenaTeede thelimbic.com/endocrinology/…

ICYMI: The NHS Type 2 Diabetes Path to Remission Programme has shown that total diet replacement supported by health coaching can encourage significant weight loss and 27% remission rates for type 2 diabetes after one year. The Lancet Diabetes & Endocrinology thelimbic.com/endocrinology/…

Clinicians should closely monitor cognitive deterioration in patients with type 2 diabetes, particularly those diagnosed at younger ages as their risk of dementia is increased thelimbic.com/neurology/deme…

Happy holidays to our readers and industry partners! Learn more about the limbic's medical news and education offerings here: thelimbic.com/about-us/?utm_…

REGISTER: thelimbic.com/endocrinology/… Tune in for an expert-led online session as they explore the practical strategies in treating & managing pituitary disorders, focusing on Cushing’s disease & andrology in pituitary patients. _______________ Endocrine Society of Australia

Type1Screen is attending the #ADC2025 currently engaged by the plenary talk from Prof Ronald Ma from The Chinese University of Hong Kong. #Diabetes in Asia is on the rise. What are the determinants and risks?

Amazing to note more adults diagnosed with #type1diabetes according to data presented by Prof Ronald Ma at #ADC2025. Test antibodies and Cpeptide at presentation. Don’t presume #type2diabetes

Head switch from covering cardiology #CSANZ2025 meeting last week to #adc2025 this week …although expecting lots of overlap. #diabetes

Interesting to hear about REGENT-1 study of pulsed electric field in T2 diabetic duodenopathy. Sham-controlled study underway. #ADC2025

Love this holding slide #ADC2025

The research journey is long but we have to be prepared to see it through. #ADC2025 - Prof David James

“The best way to get time in range for those with #type1diabetes is a pancreas transplant” says Prof Toby Coates. If only the immunosuppression wasn’t such a factor and we didn’t have to use someone else’s #pancreas 😢

Fantastic outcomes for this person with #type1diabetes who received gene modified allogenic islets hypo-immune platform (HIP) islets

We need a coordinated strategy in Australia to rethink regulatory approval and accelerate access in #type1diabetes states Dr Jennifer Snaith ⁦Garvan Institute of Medical Research⁩

Your input required: ⬇️⬇️⬇️ A cross-sectional survey of health professionals' attitudes towards islet transplantation #ADC2025 redcap.sydney.edu.au/surveys/?s=CWW…

Tips from Prof David Simmons, deserving recipient of 2025 ADS Kellion Award, after an amazing body of work across UK, NZ & Australia. #ADC2025

👏

Fabulous ADS Clinical Plenary Lecture about DKA, global consensus, why the US were wrong, the promise of continuous ketone monitoring, and more. Ketan Dhatariya = great education + extremely entertaining. Get this man back again. #ADC2025